Human testing could take up to five years to ramp up, but AI approaches will yield results in time, Karoly Nikolich says Gene-editing therapies for the nervous system may need at least another round ...
18 小时
As Acasti Pharma Advances FDA Orphan-Designated GTX-102 Oral Mucosal Spray, New Report Maps ...
Heightened clinical activity and pipeline advancement highlighted by Quince Therapeutics’ Phase 3 NEAT trial evaluation of eDSP, IntraBio’s Fast Track development of IB1001, Acasti Pharma’s ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果